Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2.
The COVID-19 pandemic has accelerated the need to identify new antiviral therapeutics at pace, including through drug repurposing. We employed a Quadratic Unbounded Binary Optimization (QUBO) model, to search for compounds similar to Remdesivir, the first antiviral against SARS-CoV-2 approved for hu...
שמור ב:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Public Library of Science (PLoS)
2022-07-01
|
| סדרה: | PLoS Computational Biology |
| גישה מקוונת: | https://doi.org/10.1371/journal.pcbi.1010330 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
